首页> Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc> Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.

Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.

导出原文传递

翻译打印收藏纠错

第一作者： Marianna,Grinberg

第一单位： Department of Statistics, TU Dortmund University, Dortmund, Germany.

作者： Marianna,Grinberg ^[1] ; Dijana,Djureinovic ^[2] ; Hans Rr,Brunnström ^[3] ; Johanna Sm,Mattsson ^[2] ; Karolina,Edlund ^[4] ; Jan G,Hengstler ^[4] ; Linnea,La Fleur ^[2] ; Simon,Ekman ^[2] ; Hirsh,Koyi ^[5] ; Eva,Branden ^[5] ; Elisabeth,Ståhle ^[6] ; Karin,Jirström ^[3] ; Derek K,Tracy ^[7] ; Fredrik,Pontén ^[2] ; Johan,Botling ^[2] ; Jörg,Rahnenführer ^[1] ; Patrick,Micke ^[2]

作者单位： Department of Statistics, TU Dortmund University, Dortmund, Germany. ^[1] Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. ^[2] Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. ^[3] Leibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund University, Dortmund, Germany. ^[4] Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden.;Centre for Research and Development, Uppsala University, County Council of Gävleborg, Gävle, Sweden. ^[5] Department of Clinical Sciences, Uppsala University, Uppsala, Sweden. ^[6] Oxleas NHS Foundation Trust, London, UK.;Cognition, Schizophrenia and Imaging Laboratory, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK. ^[7]